Status:
COMPLETED
Early Progesterone Cessation After in Vitro Fertilization
Lead Sponsor:
IVI Madrid
Conditions:
Pregnant Women
Eligibility:
FEMALE
18-40 years
Phase:
NA
Brief Summary
There seems to be a general consensus on the supplementation of progesterone (P4) for luteal phase support (LPS) to all women after in vitro fertilization (IVF) treatment. However, there is no agreeme...
Detailed Description
The objective of the study is to investigate the effect of early cessation of progesterone for LPS after IVF treatment on the pregnancy outcome, with special interest in determining the miscarriage ra...
Eligibility Criteria
Inclusion
- Patients who underwent ovarian stimulation using GnRH analogues,
- Fresh embryo transfer,
- LPS by vaginal micronized P4,
- Clinical pregnancy demonstrated by US and
- Informed consent signed.
Exclusion
- Patients who had bleeding episodes before their first US because they are likely to continue P4 therapy without medical indication.
Key Trial Info
Start Date :
January 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2010
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT01177904
Start Date
January 1 2009
End Date
January 1 2010
Last Update
April 8 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
IVI-Madrid
Madrid, Spain, 28023